Spdr S&p Biotech Etf ETF Forecast

Buy or Hold candidate since Jun 11, 2026 Gain 14.68%

The SPDR S&P Biotech ETF price gained 0.0789% on the last trading day (Thursday, 23rd Jul 2026), rising from $152.11 to $152.23. During the last trading day the ETF fluctuated 2.72% from a day low at $149.33 to a day high of $153.39. The price has been going up and down for this period, and there has been a -7.34% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 538 thousand more shares were traded than the day before. In total, 7 million shares were bought and sold for approximately $1.01 billion.

The ETF lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the ETF is expected to rise 23.34% during the next 3 months and, with a 90% probability hold a price between $177.73 and $209.11 at the end of this 3-month period.

XBI Signals & Forecast

The SPDR S&P Biotech ETF holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the ETF giving a positive forecast for the ETF. On further gains, the ETF will meet resistance from the short-term Moving Average at approximately $153.18. On a fall, the ETF will find some support from the long-term average at approximately $147.89. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -7.34%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for SPDR S&P Biotech ETF

SPDR S&P Biotech finds support from accumulated volume at $145.86 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This ETF has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the ETF moved $4.05 between high and low, or 2.72%. For the last week, the ETF has had daily average volatility of 3.01%.

Our recommended stop-loss: $143.51 (-5.73%) (This ETF has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 10 days ago.)

Trading Expectations (XBI) For The Upcoming Trading Day Of Friday 24th

For the upcoming trading day on Friday, 24th we expect SPDR S&P Biotech ETF to open at $151.65, and during the day (based on 14 day Average True Range), to move between $150.07 and $154.39, which gives a possible trading interval of +/-$4.31 (+/-2.87%) up or down from last closing price. If SPDR S&P Biotech ETF takes out the full calculated possible swing range there will be an estimated 2.87% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $154.26 (1.33%) than the support at $145.86 (4.18%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is SPDR S&P Biotech ETF ETF A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for SPDR S&P Biotech ETF to perform well in the short-term.

Current score: 1.621 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 24, 2026 - $151.65 ( 0.382%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk